Trospium Chloride Tablet, Film Coated
Product Images NDC 62135-742

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Trospium Chloride (NDC 62135-742). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chartwell Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Trospium Chloride Tab 20mg Label)

Packaging label for Trospium Chloride Tablets, USP 20 mg by Chartwell RX, LLC. The label states the product contains film-coated tablets, with a quantity of 60 tablets per container. It includes storage instructions to keep at 20 to 25°C, dispense in a child-resistant container, and references accompanying prescribing information. The label features the product NDC 62135-742 and a barcode.*

FDA Label Image

Image Description (Trospium Chloride Tab Fig1)

A line graph depicting plasma concentration (ng/mL) of trosium chloride over time (hours post-dose) up to 48 hours. Data points show a peak plasma concentration shortly after dosing with a gradual decrease and leveling off approaching zero concentration by 48 hours. Error bars indicate variability at each time point.*

FDA Label Image

Image Description (Trospium Chloride Tab Fig2)

A line graph comparing mean change (± SE) over weeks of treatment between placebo and Trospium Chloride groups. The x-axis shows weeks 1, 4, and 12; the y-axis shows mean change values. Trospium Chloride shows a greater decrease compared to placebo, with data points marked by circles (placebo) and filled circles (Trospium Chloride), and p-values indicated for statistical comparisons.*

FDA Label Image

Image Description (Trospium Chloride Tab Fig3)

A line graph comparing mean (± SE) change over weeks of treatment between placebo and Trosprium Chloride groups. The x-axis represents weeks of treatment (1, 4, 12), and the y-axis shows mean change values. Data points include sample sizes and p-values for statistical comparisons at each time point.*

FDA Label Image

Image Description (Trospium Chloride Tab Fig4)

A line graph showing the mean change over weeks of treatment comparing Tropium Chloride and placebo. The x-axis represents the weeks of treatment at 1, 4, and 12 weeks, and the y-axis shows mean change with standard error. Tropium Chloride shows a greater decrease over time compared to placebo, with p-values indicating statistical significance at all measured points.*

FDA Label Image

Image Description (Trospium Chloride Tab Fig5)

A line graph comparing mean change with standard error (SE) over 12 weeks of treatment between Trospium Chloride (N=323) and placebo (N=325). The y-axis shows mean (±SE) change, and the x-axis shows weeks 1, 4, and 12. Trospium Chloride shows a greater reduction compared to placebo at all time points, with p-values less than 0.001.*

FDA Label Image

Image Description (Trospium Chloride Tab Structure)

Chemical structure of trosium chloride depicted as a molecular diagram showing ring structures and a chloride ion (Cl-).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.